SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SNRS- Sunrise Technologies
SNRS 0.0000010000.0%Jun 6 11:01 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Sylvester who wrote (1800)11/11/1998 10:40:00 PM
From: Joe  Read Replies (2) of 4140
 
Sylvester, here's my opinion...

What has happened here is that we expected a lot of buying by the ophthalmologists attending AAO. It turns out that the company chose to offer stock in a private placement to the attendees of the meeting. It is a $10M placement and is offered in 50K share chunks. Therefore, most major investors are not buying in the open market because they can buy it at a 20% discount in the private placement. Now if it is oversubscribed, we might expect that they will go into the market and buy what they were not able to get in the placement.

Keep the faith. The stock will move up on the completion of the filing of the PMA, the placement by FDA of the PMA on a Panel meeting agenda (which occurs early February for the March 11 & 12 meeting), and recommendation by the panel for approval by the FDA. The Panel meeting recommendation will be a big move in price. Then, IMO, FDA will give a fast track approval to the safe alternative to LASIK for hyperopia and we will see another move in SNRS price. After that we will see upward moves for each quarter reporting new highs in sales and earnings.

But I think you already know all this.

Regards,

Joe
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext